Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform you that based on the recommendation of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Vivanza Biosciences, at its meeting on August 30, 2025, approved the appointment of Mr. Sarang Bharatbhai Pathak (DIN: 02663344) as an Additional Director (Non-Executive, Non-Independent), effective the same day. The appointment is subject to shareholder approval at the next general meeting. Mr. Pathak has over 20 years of experience across the service industry, business-to-government liaison, consultancy, and commodity exports and marketing. He is also the Managing Director of Adline Chem Lab Limited, another listed company, and he holds a Diploma in Civil Engineering.
This is a routine addition to the board and is unlikely to have an immediate material impact on the stock. Shareholders will get a chance to approve or reject the appointment at the upcoming general meeting.